GB Sciences Inc (GBLX)

[fast.money]

Great back-to-back news out

$GBLX also just announced the launch of new Corporate Website

Growblox Sciences Announces Launch of New Corporate Website
New Corporate Web Presence Showcases Three Operating Divisions

http://finance.yahoo.com/news/growblox-sciences-announces-launch-corporate-162143243.html

LAS VEGAS, May 11, 2015 (GLOBE NEWSWIRE) -- Growblox Sciences Inc. (GBLX) ("Growblox" or the "Company"), a biopharmaceutical research and development company with state-of-the-art technologies in plant biology and cultivation designed to produce consistent medicinal cannabis, announced today the launch of its new corporate website.

"We have navigated many obstacles in the process of refining our vision and gathering a complete understanding of the medicinal cannabis landscape. We believe that our evolution has enabled a compelling message to emerge very clearly, which we are pleased to present on our new corporate site; Growblox is here to cultivate an industry, not just a plant," said CEO Craig Ellins.

The corporate site http://www.Growblox.com provides extensive content regarding the Company's position in the market and is intended to highlight three (3) operating divisions of the Company: GB Sciences, GB Solutions and GB Products.

- GB Sciences: Handles all regulatory, compliance, clinical trials, product claim validation and new drug discovery. Led by Growblox Sciences' Chief Science Officer, Dr. Andrea Small-Howard, this division is expected to collaborate with academic and institutional partners, such as the University of Puerto Rico and various clinical research organizations, in order to create a novel cannabinoid therapy pipeline.

- GB Solutions: Focuses on supply chain and logistics and will be overseen by Puerto Rican business leader Cesar Cordero-Kruger, as head of our majority owned subsidiary Growblox Sciences Puerto Rico, LLC. Under his leadership the GB Solutions division will be responsible for all engineering, industrial design and systems validation including the commercialization of company's propriety cultivation system known as the GrowBLOX(TM) Technology Suite.

- GB Products: Expected to be formally launched by the end of Q3 2015. Lead by Growblox Sciences' Co-founder Lucas Marin, this division will be taking over product design, marketing and distribution of consumer ready cannabinoid therapies and specialized products.

The website also features the Company's focus on scientific validation for the medical cannabis industry, supply chain solutions designed to set a path for national distribution and the strong brand identities that will lead the future of cannabinoid therapies. This is the first step of the new communication strategy that the biotechnology company will deploy to target potential partners and investors in the fast growing medical cannabis space.